Join to access to all OVN content. Join for Free
How to maximize KOL engagement and MSL insights gathering at your next virtual congress with Patrina Pellet
KOL engagement MSL insights virtual congress medical strategy virtual booths

How to maximize KOL engagement and MSL insights gathering at your next virtual congress with Patrina Pellet


Share This Article


Summary

My guest today is Patrina Pellet. She is the Vice President of Medical Strategy at Kernel. We talk about how to maximize KOL engagement and MSL insights gathering at your next virtual congress.

In this episode:

  • Patrina’s article
  • Patrina’s advice on where can people start
  • Tips for folks attending (coordinating, navigating, etc)
  • Virtual booths
  • Tips on hashtags 
  • Final tip in helping others prepare and get ready
  • Tom and Patrina’s favorite quarantine activities

Click for Source
KOL engagement, MSL insights, virtual congress, medical strategy, virtual booths

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Power of Non Traditional KOL Engagement
Partner Avatar MSL Talk: Tom Caravela, Lindsey Harrer

The Power of Non Traditional KOL Engagement

Podcast
It Can be Lonely in the Life of an MSL
Partner Avatar MSL Talk: Tom Caravela, Trish Gorecki

It Can be Lonely in the Life of an MSL

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN